Sign In
Buy ESPR
$3.14
+0 (+0%)
At Close: Jun 03, 2026
Why Esperion Therapeutics Plummeted by 11% Today
05:51pm, Monday, 25'th Oct 2021
Shareholders were displeased with the company's latest financial move.
ESPR Stock: Why It Increased Today
03:34pm, Tuesday, 19'th Oct 2021
The stock price of Esperion Therapeutics Inc (NASDAQ: ESPR) increased by over 6% during intraday trading today. This is why it happened.
Tuesday Afternoon Analyst Upgrades and Downgrades: CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and More
03:18pm, Tuesday, 19'th Oct 2021
Another day of strong earnings is pushing the broad markets higher across the board.
Esperion Chops 40% Workforce As Launch Of Cholesterol Medication Falters
05:54pm, Monday, 18'th Oct 2021
Esperion Therapeutics Inc's (NASDAQ: ESPR) cholesterol drug marketing strategy has soured badly, as it has been struggling to sell its heart disease pill for more than a year. What Happened: The Com
Esperion Therapeutics to reduce workforce by 40%
07:59am, Monday, 18'th Oct 2021
Shares of Esperion Therapeutics Inc. ESPR, -1.72% were down 1.5% in premarket trading on Monday after the company said it plans to reduce its workforce by 40%, citing the challenges of launching two c
ESPERION Announces Plan for Transformative Long-Term Growth
07:00am, Monday, 18'th Oct 2021
– Optimizes organizational structure and operational processes to enable growth as the Company anticipates an inflection post the read-out of the CLEAR Outcomes trial –
ESPERION to Host Investor Webinar on the Current Landscape and Future Directions in the Treatment of Elevated Cholesterol
04:01pm, Tuesday, 07'th Sep 2021
ANN ARBOR, Mich., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), the lipid management company, today announced that it will host an investor webinar on the current landscape and future di
Esperion to Participate in Upcoming Virtual Investor Conference
08:00am, Thursday, 26'th Aug 2021
ANN ARBOR, Mich., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that members of Esperion's management team will participate in the upcoming Morgan Stanley 19th Annual Globa
Esperion: Hunting Big Game In The Danger Zone
09:58pm, Wednesday, 04'th Aug 2021
Esperion's sales following its twin therapy approval have been slow to develop.Esperion's products are entering a crowded marketplace with significant price competition.
Esperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q2 2021 Results - Earnings Call Transcript
12:43pm, Tuesday, 03'rd Aug 2021
Esperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q2 2021 Results - Earnings Call Transcript
Esperion Therapeutics (ESPR) Reports Q2 Loss, Misses Revenue Estimates
09:56am, Tuesday, 03'rd Aug 2021
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 8.24% and -1.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Esperion Therapeutics Q2 Earnings
07:42am, Tuesday, 03'rd Aug 2021
Shares of Esperion Therapeutics (NASDAQ:ESPR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share were down 138.66% over the past year to ($1.67), which bea
7 Names That Could Be The Next Short-Squeeze Stocks
04:58pm, Monday, 12'th Jul 2021
Many investors are taking advantage of short-squeeze stocks by buying heavily shorted stocks when trading at or near all-time lows. The post 7 Names That Could Be The Next Short-Squeeze Stocks appeare
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05:00pm, Thursday, 01'st Jul 2021
ANN ARBOR, Mich., July 01, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that, on June 28, 2021, the Compensation Committee of Esperion's Board of Directors granted 31 new employees
Esperion Shorts Have Cleaned Up
03:01pm, Thursday, 01'st Jul 2021
Short-sellers who made a bet on Esperion Therapeutics Inc. ( ESPR , Financial) have done well during the past year, but is it time to cash out? While Experion's share price has been cut nearly $30 to
